Abbott Laboratories' SWOT analysis: medtech giant's stock faces litigation...

Published on 16 Dec 2024 on Investing.com

Abbott Laboratories (NYSE:ABT), a leading player in the medical technology sector with a market...

Read the rest of the article

Start tracking your investments with Statfolio

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:...

CNBC 20 Dec 2024

Omnicell's restructuring and cost-saving measures are also likely to drive major operational...

Zacks · via Yahoo Finance 20 Dec 2024

Abbott Laboratories’ ABT growth in the third quarter of 2024 can be attributed to strong sales re...

Zacks · via Yahoo Finance 19 Dec 2024

Whatever the answer is, it probably won't be dividend investing. Let's consider two income-focuse...

Motley Fool · via Yahoo Finance 19 Dec 2024

The latest development is expected to strengthen Abbott’s Cardiac Rhythm Management business, par...

Zacks · via Yahoo Finance 18 Dec 2024

It is hard to get excited after looking at Abbott Laboratories' (NYSE:ABT) recent performance, wh...

Simply Wall St. · via Yahoo Finance 17 Dec 2024

DexCom (NASDAQ:DXCM), Inc., a leader in continuous glucose monitoring (CGM) systems for diabetes...

Investing.com 16 Dec 2024

Abbott Laboratories (NYSE:ABT), a leading player in the medical technology sector with a market...

Investing.com 16 Dec 2024

The company has raised its dividend by an impressive average of 14% annually over the past decade...

Motley Fool · via Yahoo Finance 15 Dec 2024

Stocks in Gurus' Portfolio This Powerful Chart Made Peter Lynch 29% A Year For 13 Years How to...

GuruFocus.com · via Yahoo Finance 13 Dec 2024